Evaluation on Inter-Assay Consistency and Inter-Reader Precision for PD-L1 Assays: Ventana SP263 and Dako 22C3 in Non-Small Cell Lung Cancer

被引：1
作者：
Lin, D. [1 ]
Yang, X. [1 ]
机构：
[1] Peking Univ, Canc Hosp & Inst, Key Lab Carcinogenesis & Translat Res, Dept Pathol,Minist Educ, Beijing, Peoples R China
来源：
JOURNAL OF THORACIC ONCOLOGY | 2019年 / 14卷 / 10期
关键词：
PD-L1; Assays; TPS; Non-Small Cell Lung Cancer;
D O I：
10.1016/j.jtho.2019.08.1663
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P2.09-14
引用
收藏
页码：S774 / S774
页数：1
相关论文
共 50 条
  • [21] High Concordance of PD-L1 Antibody Between Clone 22C3 and Clone E1L3N in Non-Small Cell Lung Cancer Biopsy Samples
    Zhang, W.
    Wu, C.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S782 - S782
  • [22] The Clinicopathological and Molecular Associations of PD-L1 Expression in Non-small Cell Lung Cancer: Analysis of a Series of 10,005 Cases Tested with the 22C3 Assay
    Evans, Matthew
    O'Sullivan, Brendan
    Hughes, Frances
    Mullis, Tina
    Smith, Matthew
    Trim, Nicola
    Taniere, Philippe
    PATHOLOGY & ONCOLOGY RESEARCH, 2020, 26 (01) : 79 - 89
  • [23] Updated Analysis of Outcomes by Histology vs Cytology PD-L1 22C3 Antibody Testing in Advanced Non-Small Cell Lung Cancer
    Sathiyapalan, A.
    Wang, Y.
    Juergens, R.
    Butcher, M.
    Naqvi, A.
    Cutz, J.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S379 - S380
  • [24] SP142 PD-L1 Scoring Shows High Interobserver and Intraobserver Agreement in Triple-negative Breast Carcinoma But Overall Low Percentage Agreement With Other PD-L1 Clones SP263 and 22C3
    Pang, Jia-Min B.
    Castles, Belinda
    Byrne, David J.
    Button, Peter
    Hendry, Shona
    Lakhani, Sunil R.
    Sivasubramaniam, Vanathi
    Cooper, Wendy A.
    Armes, Jane
    Millar, Ewan K. A.
    Raymond, Wendy
    Roberts-Thomson, Samuel
    Kumar, Beena
    Burr, Marian
    Selinger, Christina
    Harvey, Kate
    Chan, Charles
    Beith, Jane
    Clouston, David
    O'Toole, Sandra A.
    Fox, Stephen B.
    AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2021, 45 (08) : 1108 - 1117
  • [25] Evaluating programmed death-ligand 1 (PD-L1) in head and neck squamous cell carcinoma: concordance between the 22C3 PharmDx assay and the SP263 assay on whole sections from a multicentre study
    Cerbelli, Bruna
    Girolami, Ilaria
    Eccher, Albino
    Costarelli, Leopoldo
    Taccogna, Silvia
    Scialpi, Renzo
    Benevolo, Maria
    Lucante, Teresa
    Alo, Piero Luigi
    Stella, Francesca
    Pignataro, Maria Gemma
    Fadda, Guido
    Perrone, Giuseppe
    D'Amati, Giulia
    Martini, Maurizio
    HISTOPATHOLOGY, 2022, 80 (02) : 397 - 406
  • [26] Using 22C3 Anti-PD-L1 Antibody Concentrate on Biopsy and Cytology Samples from Non-small Cell Lung Cancer Patients
    Ilie, Marius
    Ngo-Mai, Melanie
    Long-Mira, Elodie
    Lassalle, Sandra
    Butori, Catherine
    Bence, Coraline
    Hamila, Marame
    Hofman, Veronique
    Hofman, Paul
    JOVE-JOURNAL OF VISUALIZED EXPERIMENTS, 2018, (139):
  • [27] Intra- and Inter-Observer Reproducibility Study of PD-L1 Biomarker in Non-Small Cell Lung Cancer (NSCLC) - The DREAM STUDY
    Cooper, Wendy
    Russell, Prudence
    Huot-Marchand, Phillipe
    Cherian, Maya
    Duhig, Edwina
    Godbolt, David
    Jessup, Peter
    Khoo, Christine
    Leslie, Connull
    Mahar, Annabelle
    Moffat, David
    Sivasubramaniam, Vanathi
    Grattan, Amanda
    Reznichenko, Alena
    Woodgate, Ann-Marie
    Fox, Sephen
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S814 - S815
  • [28] PD-L1 expression heterogeneity in non-small cell lung cancer: evaluation of small biopsies reliability
    Munari, Enrico
    Zamboni, Giuseppe
    Marconi, Marcella
    Sommaggio, Marco
    Brunelli, Matteo
    Martignoni, Guido
    Netto, George J.
    Moretta, Francesca
    Mingari, Maria Cristina
    Salgarello, Matteo
    Terzi, Alberto
    Picece, Vincenzo
    Pomari, Carlo
    Lunardi, Gianluigi
    Cavazza, Alberto
    Rossi, Giulio
    Moretta, Lorenzo
    Bogina, Giuseppe
    ONCOTARGET, 2017, 8 (52): : 90123 - 90131
  • [29] Programmed cell death ligand-1 (PD-L1) expression in extrahepatic biliary tract cancers: a comparative study using 22C3, SP263 and E1L3N anti-PD-L1 antibodies
    Ahn, Soomin
    Lee, Yangkyu
    Kim, Ji-Won
    Lee, Jong-Chan
    Hwang, Jin-Hyeok
    Yoon, Yoo-Seok
    Cho, Jai Young
    Han, Ho-Seong
    Choi, YoungRok
    Kim, Haeryoung
    HISTOPATHOLOGY, 2019, 75 (04) : 526 - 536
  • [30] Mitomycin C synergizes with PD-L1 blockade in treatment of non-small cell lung cancer
    LUO Min
    ZHANG Hong
    WU Shao-cong
    CHEN Zhen
    LIANG Shao-bo
    WANG Fang
    FU Li-wu
    中国药理学与毒理学杂志, 2019, (10) : 885 - 885
12345